Literature DB >> 2049243

Proceedings of the British Pharmacological Society. 12-14 September 1990, Belfast.

.   

Abstract

Mesh:

Year:  1991        PMID: 2049243      PMCID: PMC1368401          DOI: 10.1111/j.1365-2125.1991.tb05523.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  61 in total

1.  Reserpine, para-chlorophenylalanine and fenfluramine antagonise cisplatin-induced emesis in the ferret.

Authors:  J M Barnes; N M Barnes; B Costall; R J Naylor; F D Tattersall
Journal:  Neuropharmacology       Date:  1988-08       Impact factor: 5.250

2.  Raised serum lipoprotein during treatment with lovastatin.

Authors:  G Jürgens; A Ashy; G Zenker
Journal:  Lancet       Date:  1989-04-22       Impact factor: 79.321

3.  Determination of halofantrine and its principal metabolite desbutylhalofantrine in biological fluids by reversed-phase high-performance liquid chromatography.

Authors:  K A Milton; S A Ward; G Edwards
Journal:  J Chromatogr       Date:  1988-12-09

4.  Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk.

Authors:  N H Shear; S P Spielberg
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

Review 5.  Felodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.

Authors:  E Saltiel; A G Ellrodt; J P Monk; M S Langley
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

6.  2-Fluoroestradiol. Separation of estrogenicity from carcinogenicity.

Authors:  J G Liehr
Journal:  Mol Pharmacol       Date:  1983-03       Impact factor: 4.436

7.  Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.

Authors:  S De Wit; D Weerts; H Goossens; N Clumeck
Journal:  Lancet       Date:  1989-04-08       Impact factor: 79.321

8.  Does placebo lower blood-pressure?

Authors:  B A Gould; S Mann; A B Davies; D G Altman; E B Raftery
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

9.  Nifedipine: individual responses and concentration-effect relationships.

Authors:  R Donnelly; H L Elliott; P A Meredith; A W Kelman; J L Reid
Journal:  Hypertension       Date:  1988-10       Impact factor: 10.190

10.  The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist.

Authors:  H Giles; P Leff; M L Bolofo; M G Kelly; A D Robertson
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.